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PCardiac Imaging
Delayed-Enhanced Magnetic Resonance
Imaging in Nonischemic Cardiomyopathy
Utility for Identifying the Ventricular Arrhythmia Substrate
Frank M. Bogun, MD, Benoit Desjardins, MD, PHD, Eric Good, DO, Sanjaya Gupta, MD,
Thomas Crawford, MD, Hakan Oral, MD, Matthew Ebinger, DO, Frank Pelosi, MD,
Aman Chugh, MD, Krit Jongnarangsin, MD, Fred Morady, MD
Ann Arbor, Michigan
Objectives The purpose of this study was to assess the value of delayed-enhanced magnetic resonance imaging (DE-MRI) to
guide ablation of ventricular arrhythmias in patients with nonischemic cardiomyopathy (NIC).
Background In patients with NIC, ventricular arrhythmias often are associated with scar tissue. DE-MRI can be used to pre-
cisely define scar tissue.
Methods DE-MRI was performed in 29 consecutive patients (mean age 50  15 years) with NIC (mean ejection fraction
37  9%) referred for catheter ablation of ventricular tachycardia (VT) or premature ventricular complexes
(PVCs). Scar was extracted from DE-MRIs and was then integrated into the electroanatomic map. Mapping data
were correlated with respect to the localization of scar tissue.
Results Scar was identified by DE-MRI in 14 of 29 patients. Nine of these patients had VT and 5 had PVCs. In 5 of the
patients there was predominantly endocardial scar, and mapping and ablation of arrhythmias was effectively
performed from the endocardium in all 5 patients. In 2 patients scar was either intramural or epicardial with
extension to the endocardium. In both patients with partial endocardial scar extension, the ablation was effec-
tive in eliminating some but not all arrhythmias. In 2 patients most of the scar tissue was confined to the epicar-
dium; mapping identified and eliminated an epicardial origin in both patients. No effect on arrhythmias could be
achieved in the other 5 patients with predominantly intramural scar.
Conclusions DE-MRI in patients without prior infarctions can help to identify the arrhythmogenic substrate; furthermore, it
helps to plan an appropriate mapping and ablation strategy. (J Am Coll Cardiol 2009;53:1138–45) © 2009 by
the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.11.052a
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bn patients with ischemic and nonischemic cardiomyopathy,
entricular arrhythmias are often associated with the pres-
nce of scar tissue (1–3). Whereas scar tissue in post-
nfarction patients is commonly located in the subendocar-
ium (4), scar in patients with nonischemic cardiomyopathy
See page 1146
s often found in the midmyocardium (4) or the epicardium
5). Delayed-enhanced magnetic resonance imaging (DE-
RI) precisely defines the extent and location of scar tissue
nd therefore might be a useful guide to mapping and
rom the University of Michigan Medical Center, Ann Arbor, Michigan. Drs.
orady and Oral are cofounders and equity owners of Ablation Frontiers, and Dr.
ral has received research grants from Boston Scientific and St. Jude Medical.w
Manuscript received July 28, 2008; revised manuscript received November 12,
008, accepted November 24, 2008.blation of ventricular arrhythmias in patients with nonisch-
mic cardiomyopathy.
The purpose of this study was to determine whether
E-MRI is a useful guide to mapping and ablation of
entricular arrhythmias in patients with nonischemic car-
iomyopathy.
ethods
atient characteristics. The subjects of this study were 29
onsecutive patients (mean age 50  15 years, 13 women)
ith nonischemic cardiomyopathy (mean ejection fraction
9  9%) referred for radiofrequency catheter ablation of
ymptomatic premature ventricular complexes (PVCs) (n 
0), or ventricular tachycardia (VT) (n 9) (Table 1). None
f the patients had contraindications for magnetic resonance
maging (MRI). In patients with frequent PVCs, the PVC
urden was 29  18% of the total QRS count. Treatment
ith a mean of 1.5  0.9 antiarrhythmic medications
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March 31, 2009:1138–45 DE-MRI and Arrhythmia in Cardiomyopathyincluding amiodarone in 6 patients) had been unsuccessful.
ll patients underwent DE-MRI before the catheter abla-
ion procedure.
ardiac MRI. The DE-MRI studies were performed on a
.5-T magnetic resonance imaging scanner (Signa Excite
V/i, General Electric, Milwaukee, WI) with a 4- or
-element phased-array coil placed over the chest of patients
n the supine position. Images were acquired with electro-
ardiographic gating during breath-holds. Dynamic short-
nd long-axis images of the heart were acquired using a
egmented, k-space, steady-state, free-precession pulse se-
uence (repetition time 4.2 ms, echo time 1.8 ms, 1.4  1.4
m in-plane spatial resolution, 8-mm slice thickness). Fifteen
inutes after administration of 0.20 mmol/kg of intravenous
adolinium DTPA (Magnevist, Berlex Pharmaceuticals,
ayne, New Jersey), 2-dimensional delayed-enhancement
maging was performed using an inversion-recovery sequence
6) (repetition time 6.7 ms, echo time 3.2 ms, in-plane spatial
esolution 1.4  2.2 mm, slice thickness 8 mm) in the short-
nd long-axis of the left ventricle at matching cine-image slice
ocations. The inversion time (250 to 350 ms) was optimized to
ull the normal myocardium. The DE-MRIs were reviewed
or the presence or absence of delayed enhancement by 2
bservers blinded to the results of mapping and ablation (Table
). Discrepancies were resolved by consensus.
lectrophysiologic study and mapping. The study proto-
ol was approved by the Human Research Committee.
fter informed consent was obtained, a 6-F quadripolar
lectrode catheter was introduced into the right femoral vein
nd positioned at the right ventricular apex. Programmed
ight ventricular stimulation was performed in all patients
ith 1 to 4 extrastimuli to induce VT. Sustained VT was
efined as VT lasting 30 s or requiring termination
econdary to hemodynamic compromise of the patient. In 9
f 28 patients, sustained monomorphic VT could be in-
uced. In these 9 patients a total of 49 distinct, sustained,
onomorphic VTs could be induced (mean of 7  7 VTs
er patient). The VTs had a mean cycle length of 366  78
atient Characteristics
Table 1 Patient Characteristics
Characteristics
Scar by
DE-MRI
No Scar by
DE-MRI p Value
n 14 15
Age (yrs) 52 13 48 17 0.5
Sex (male/female) 9/5 7/8 0.5
Ejection fraction 0.38 0.09 0.36 0.09 0.5
MRI
Volume end diastolic (ml) 194 56 184 72 0.7
LV mass (cm3) 172 53 130 46 0.07
Spontaneous or inducible VT 9/14 0/15 0.001
Frequent PVCs 7/14 15/15 0.001
SOO of PVCs (RV/LV) 0/4 7/7 0.1
Effective ablation sites of VTs
(RV/LV) per patient
3/4 0/0 1
E-MRI  delayed enhanced magnetic resonance imaging; LV  left ventricle/ventricular; PVC v
remature ventricular complex; RV  right ventricle/ventricular; SOO  site of origin; VT 
entricular tachycardia.s. Thirteen had a right bundle
ranch block morphology, and
8 had a left bundle branch block
orphology.
Electroanatomical mapping
CARTO, Biosense Webster, Di-
mond Bar, California) was per-
ormed with either a 4-mm-tip
blation catheter (Navistar) or a
.5-mm-tip, open-irrigation ab-
ation catheter (Thermocool)
both from Biosense Webster).
ultielectrode catheters were po-
itioned in the high right atrium,
he His position, and the right ventricular apex. Electrograms
ere filtered at 50 to 500 Hz. The intracardiac electrograms
nd leads V1, I, II, and III were displayed on an oscilloscope
nd recorded at a speed of 100 mm/s. The recordings were
tored on optical disc (EP Med, West Berlin, New Jersey).
epending on the morphology of the targeted ventricular
rrhythmias, mapping was performed in the right ventricle (for
eft bundle branch block ventricular arrhythmias) or the left
entricle (for right bundle branch block arrhythmias). A
oltage map was generated during sinus rhythm, followed by
ctivation mapping and/or entrainment mapping of the tar-
eted PVCs or VT in the right or left ventricle, as appropriate.
For PVCs, the site with the earliest local activation time
esulting in elimination of the PVC during radiofrequency
blation was defined as critical. For hemodynamically tol-
rated VT, a site was defined as critical in the presence of
oncealed entrainment resulting in VT termination during
adiofrequency energy delivery or in the presence of termi-
ation of a VT by mechanical contact with the mapping
atheter. For nontolerated VTs, an isthmus was defined as
site where a match of the QRS morphology between the
ace map and the VT could be identified.
Low voltage was defined as a bipolar voltage amplitude of
1.5 mV (7). Areas with bipolar voltage 1.5 and 1.0
V were measured. Activation time was measured with
lectronic calipers from the onset of the first rapid compo-
ent of the ventricular electrogram to the beginning of the
RS complex. If a VT was hemodynamically tolerated,
ntrainment mapping was also performed. If PVCs were
nfrequent or if a targeted VT was not hemodynamically
olerated, pace mapping was used to identify the site of
rigin. In case of left ventricular mapping, a bolus of 5,000
of heparin was used initially and heparin was then
dministered to obtain an activated clotting time of 300 s.
or right-sided procedures, an initial bolus of 3,000 U of
eparin was given followed by 1,000 U of heparin every
our. In case of an epicardial procedure, heparin was only
dministered after the pericardial puncture was performed.
A 2.5-F electrode catheter (Cardima, Inc., Pathfinder,
remont, California) was introduced into the coronary
Abbreviations
and Acronyms
3D  three-dimensional
DE-MRI  delayed-
enhanced magnetic
resonance imaging
MRI  magnetic resonance
imaging
PVC  premature
ventricular complexes
VT  ventricular
tachycardiaenous system in 3 patients in whom an epicardial origin of
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DE-MRI and Arrhythmia in Cardiomyopathy March 31, 2009:1138–45ventricular arrhythmia was suspected. In 1 patient, epi-
ardial mapping and ablation was performed using percu-
aneous access (8) after an ineffective endocardial mapping
nd ablation.
egistration of DE-MRI and electroanatomic mapping
ata. Before the procedure, scar tissue was identified on the
E-MRI (Fig. 1). On each short-axis DE-MRI image,
ith reference to long-axis DE-MRI images and short and
ong axis steady-state, free-precession dynamic images, the
ollowing contours were manually traced: the endocardial
nd epicardial contours of both the left and right ventricles
Figure 1 Stack of Short-Axis DE-MRI Pictures Showing Delayed
Although the free wall is thinned, the endocardium is relatively preserved. The epic
catheter ablation procedure for VT was unsuccessful. Epicardial ablation successf
nance imaging; VT  ventricular tachycardia.
car Characteristics of Patients With LV or RV Scar as Detected b
Table 2 Scar Characteristics of Patients With LV or RV Scar as
Patient #
Underlying
Heart Disease
RV Normal Volume/Scar Volume
(cm3)
1 Sarcoidosis 79.9/111.5
2 DCM 54.9/0
3 Sarcoidosis 45.3/1.9
4 DCM 34.1/0
5 Sarcoidosis 41.4/0
6 DCM 56.6/0
7 DCM 53.5/0
8 DCM 43.3/0
9 DCM 31.4/0
10 DCM 68.5/29.7
11 DCM 58.3/0
12 DCM 25.6/0
13 DCM 30.7/0
14 DCM 28/0
CM  dilated crardiomyopathy; DE-MRI  delayed-enhanced magnetic resonance imaging; End
ransmural.nd each area of abnormal signal in the left or right
entricular myocardium. Then, using customized software
n the MATLAB environment (MathWorks, Natick, Mas-
achusetts), 3-dimensional (3D) endocardial and epicardial
urfaces were generated for both the left and right ventricles.
n addition, for each area of abnormal signal in the left and
ight ventricular myocardium, a 3D surface representation
f the distribution of this abnormal signal was produced
Figs. 2A and 2B).
This was performed by first transforming the 3D surface
ap data into volumetric data corresponding to each sur-
ancement in the Epicardial Left Ventricular Lateral Wall
contours of the scar are traced in dotted lines. An endocardial radiofrequency
minated all 3 inducible VTs. DE-MRI  delayed-enhancement magnetic reso-
MRI
ected by DE-MRI
ormal Volume/Scar Volume
(cm3)
LV Scar %
of Total LV
LV Scar Distribution
Trm/End/Intr/Epi (%)
272/71.6 21 71/8/7/14
234/11.21 5 0/13/80/7
145.7/14.4 10 0/17/76/6
133.5/25.2 19 0/0/85/15
148.3/21.6 15 0/0/11/89
274.2/5.0 1.8 0/100/0/0
180.1/21.9 12 0/100/0/0
194.4/1.1 0.5 0/100/0/0
137.4/8.7 6 24/0/76/0
165.5/32.2 19.5 0/24/26/50
159/6.5 4 0/0/0/100
100/0.2 .2 0/0/100/0
127.8/21.5 17 88/12/0/0
109/11 10 0/0/100/0
ocardial; Epi  epicardial; Intr  intramural; LV  left ventricular; RV  right ventricular; Trm Enh
ardial
ully eliy DE-
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March 31, 2009:1138–45 DE-MRI and Arrhythmia in Cardiomyopathyace, and importing this 3D volumetric DICOM data into
he CARTO MERGE software (Biosense Webster) using
ts standard volumetric data import functionality. Within
he CARTO MERGE software, the 3D surfaces were
ecreated by segmentation of the imported volumetric data.
D registration of the MRI surface data (Fig. 2B) and the
lectroanatomic mapping data (Fig. 2C) was initially ac-
omplished using 3 fixed reference points (aorta, left ven-
ricular apex, and mitral annulus) of both MRI data and
lectroanatomic mapping data, and then refined using
urface registration. Mitral annular points sites were selected
n the electroanatomic map where both atrial and ventric-
lar signals were present. Using this approach, a 3D
egistration of both image modalities could be achieved with
n accuracy of 5 mm as assessed by surface registration
tatistics. The electroanatomic map was then fused to the
ndocardial surface within the CARTO MERGE software
Fig. 2D).
adiofrequency ablation. Radiofrequency energy was
Figure 2 3-Dimensional Display and Integration of Scar Within
(A) The 3-dimensional display of scar tissue (gray) that was extracted from the DE
The 3-dimensional display of scar (orange) and the surrounding epicardium (green
inferolateral aspect of the scar extending from the left ventricular base to the ape
scar shown in A and B corresponds with the low-voltage area shown here. (D) Me
MRI. The region of low voltage corresponds to the location of the DE-MRI scar. Abelivered at sites of earliest endocardial activation during lVCs, at sites with concealed entrainment during VT, or
t sites of origin as determined by pace mapping. For
onirrigated catheters, the target temperature was set to
0°C; for irrigated tip catheters, the initial power setting
as 30 W; applications of radiofrequency energy were
itrated to achieve an impedance decrease of 10 ohms.
blation was performed during ventricular ectopy or VT
henever possible and energy applications were contin-
ed for 30 s if adequate heating at the electrode–tissue
nterface was achieved. If the PVCs or VT ceased within
0 s, the energy application was continued for 60 s and
as followed by a second 60-s application. If the PVCs or
T did not cease in 30 s, the radiofrequency energy
pplication was discontinued and additional mapping
as performed. In the pericardial space, only nonirrigated
ip catheters were used with a target temperature of 60°C.
n the coronary venous system, irrigated-tip catheters
ere used for ablation with an initial power setting of 15
. After ablation, programmed right ventricular stimu-
lectroanatomic Map
shown in Figure 1. The inferolateral aspect of the epicardial scar is shown. (B)
e left ventricle. The heart is oriented in the same manner as in A, showing the
An epicardial voltage map. Low-voltage areas (1.5 mV) are shown in red. The
f the voltage map with the 3-dimensional reconstruction of the scar seen on DE-
ions as in Figure 1.the E
-MRI
) of th
x. (C)
rging o
breviatation was repeated. Successful catheter ablation was
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DE-MRI and Arrhythmia in Cardiomyopathy March 31, 2009:1138–45efined as cessation of the targeted PVCs or the nonin-
ucibility of VT.
ata analysis. Scar volume (cm3) and endocardial as well
s epicardial scar area (cm2) was determined after endocar-
ial and epicardial contours were manually traced and areas
ith delayed enhancement were identified and traced.
ocation of scar was classified as predominantly endocardial
Fig. 3), predominantly epicardial (Fig. 1), or transmural if
ndocardial and epicardial areas were involved (Fig. 3). The
ntramural scar component was quantified as 100% if there
as no extension to epicardial or endocardial surface (Fig. 4)
nd 100% in case of extension to endocardium/
picardium (Fig. 4). The distribution of areas with delayed
nhancement was classified as monofocal (Fig. 1) or multi-
ocal (Figs. 3 and 4).
For right ventricular scar, scar was defined as present or
bsent. If the septum revealed scar on the right ventricular
ndocardium, this was considered to be right ventricular
car.
ollow-up. All patients were seen in follow-up 3 to 6
onths after the ablation procedure. Patients with implant-
ble cardioverter-defibrillators were seen every 6 months in
device clinic. The mean duration of follow-up was 19 
1 months. Post-ablation antiarrhythmic medication was
ontinued in 4 patients in whom the ablation was consid-
red to be only partially effective (n  2) or ineffective (n 
). In the remaining patients, antiarrhythmic medications
ere not continued.
tatistical analysis. Variables are expressed as the mean 
standard deviation. Variables were compared by the
tudent t test, the Fisher exact test, or by chi-square
Figure 3 A Short-Axis View of the
Midportion of the Right and Left Ventricles
The scar involves predominantly the right ventricular endocardium. The right
ventricle shows endocardial delayed enhancement (arrows) that is transmural
in the right ventricular free wall and mostly endocardial at the right ventricular
septum. Endocardial scar also is present in the left ventricle, with some trans-
mural components. All 4 inducible VTs were ablated at the right ventricular
endocardium in this patient. Abbreviations as in Figure 1.nalysis, as appropriate. If a cell size was 5, the Fisherxact test was used. Changes in the PVC burden and
hanges in ejection fraction were assessed by paired t tests.
earson correlation coefficient (R) was calculated to assess
inear relationship between 2 continuous variables. A value
f p  0.05 was considered statistically significant.
esults
indings on DE-MRI. In 14 of 29 cardiac MRIs there
as evidence of delayed enhancement in the MRIs (Table
). Delayed enhancement was either present in a single
ocus (n  6) or was multifocal (n  8). It affected the left
entricle in all 14 patients; right ventricular involvement was
resent in 3 of 14 patients. The distribution was predomi-
antly endocardial (n  7, with intramural extension in 2 of
), midmyocardial (n  5), or epicardial (n  2). If an
lectroanatomic map was performed in the chamber or
urface displaying DE, there was always low voltage present
atching with the area of DE (Fig. 2). Endocardial size of
he scar as assessed by DE-MRI (26  34 cm2) correlated
ell with the endocardial scar size as defined by voltage
apping (1.0 mV: 33  42 cm2; R  0.96; p  0.0001,
nd 1.5 mV: 45  14 cm2, R  0.94; p  0.0001). Image
egistration of the 3D MRI volume of the chamber in which
apping was performed resulted in a positional error of 4.8
3.6 mm with surface registration. Eighty-seven percent of
ow-voltage points projected on scar tissue.
Figure 4 A Short-Axis View of the
Midportion of the Left Ventricle
There is delayed enhancement that is predominantly midmyocardial at the infe-
rior free wall. The scar is intramural (arrows) and extends to the epicardium,
with sparing of the endocardium. The scar located at the posteroseptal wall is
completely intramural (arrows). Endocardial radiofrequency catheter ablation
was unsuccessful in this patient. Limited epicardial mapping from within the
coronary sinus did not show early activation during the induced VTs, and map-
ping was not performed within the pericardial space. Abbreviations as in
Figure 1.
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March 31, 2009:1138–45 DE-MRI and Arrhythmia in Cardiomyopathyelationship between DE-MRI and results of catheter
apping. All of the patients with inducible VT or a history
f sustained VT had evidence of delayed enhancement
Tables 2 to 4). In each patient in whom delayed enhance-
ent was present and in whom a critical component of an
rrhythmia could be identified, the critical component of
he arrhythmia was confined to the scar tissue. Isolated
otentials could be identified in all of the patients showing
elayed enhancement on the MRI unless the scar was
ntramural in location. After integration of the scar into the
lectroanatomic map, activation/entrainment and or pace
apping confirmed that the critical area for ventricular
rrhythmias was confined to endocardial scar tissue in 7 of
4 patients (50%) with delayed enhancement. Epicardial
apping and ablation identified critical components of VT
onfined to epicardial scar in 2 of 14 patients (14%) with
elayed enhancement. In 5 of 14 patients (36%) with
argeted Arrhythmias With Mapping and Ablation Sites
Table 3 Targeted Arrhythmias With Mapping and Ablation Sites
Patient #
Inducible VT/
Spontaneous VT
No. of Inducible VTs/
Targeted PVCs
No. of Targeted
RV Arrhythmias
1 Yes/Yes 4/0 4
2 Yes/Yes 12/0 0
3 Yes/Yes 6/0 0
4 Yes/Yes 1/0 0
5 Yes/Yes 3/0 0
6 No/No 0/1 0
7 Yes/No 1/1 0
8 No/No 0/3 0
9 No/No 0/7 0
10 Yes/No 21/0 14
11 No/Yes 1/1 0
12 No/No 0/1 1
13 Yes/Yes 1/0 1
14 No/No 0/2 0
A  not applicable; PVC  premature ventricular contraction; RF  radiofrequency ablation; VT
car Involvement Relative to Mapped Chamber and Identification o
Table 4 Scar Involvement Relative to Mapped Chamber and Ide
Patient # Mapped Chamber
Scar Involving
Endocardium of
Mapped Chamber (%) A
1 RV 100
2 LV 13
3 LV 17
4 LV 0
5 LV endocardium Endocardial: 0
LV epicardium Epicardial: 100
6 LV endocardium 100
7 LV endocardium 100
8 LV endocardium 100
9 LV endocardium 23
10 RV/LV endocardium 100/24
11 LEMO NA
12 LV 0
13 LV endocardium 100
14 LV endocardium/LEMO 0EMO  limited epicardial mapping only; SOO  site of origin; other abbreviations as in Tables 2 and 3.elayed enhancement, scar was predominantly located in-
ramurally, and an ablation procedure was ineffective.
In the 7 patients in whom ventricular arrhythmias could
e identified in an area of endocardial scar, all arrhythmias
VT in 4 patients and PVCs in 3 patients) were confined to
he endocardium in 5 of 7 patients. In the remaining 2
atients, although there was an endocardial extension of the
car, the majority of the scar (80%) was intramural in 1
atient and was intramural or extended to the epicardium
here mapping was not performed in another patient.
ritical areas for arrhythmias (both patients with VT) could
e identified at the endocardium for 20 of 33 VTs in both
atients. In the 2 patients in whom the scar was limited to
he epicardium, 1 had a prior failed ablation. In this patient
transcutaneous puncture of the pericardial space followed
y epicardial mapping delineated the epicardial extent of the
car and allowed localization of critical components for all 3
Effective RV
docardial Ablation
No. of Targeted
LV Arrhythmias
Effective LV
Endocardial RF
Effective
Epicardial RF
4 0 NA NA
NA 12 4 NA
NA 6 0 0
NA 1 0 0
NA 3 0 3
NA 1 1 NA
NA 2 2 NA
NA 3 3 NA
NA 7 0 0
11 7 5 0
NA 2 0 2
NA 1 0 NA
NA 1 1 NA
NA 2 0 NA
ricular tachycardia; other abbreviations as in Table 2.
get Sites
ation of Target Sites
lated
mias (%)
Scar Involving Intramural
or Epicardial Part of
Mapped Chamber (%)
Limited Epicardial Mapping
Identifying SOO
(Mapped Arrhythmias, %)
00 0 NA
33 87 NA
0 82 0
0 100 0
0 0 NA
00 100
00 0 NA
00 0 NA
00 0 NA
0 76 0
/71 0/76 0
00 100 100
0 100 NA
00 0 NA
0 100 0Enf Tar
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DE-MRI and Arrhythmia in Cardiomyopathy March 31, 2009:1138–45nducible VTs. In the other patient, a limited epicardial
apping procedure via the coronary venous system identi-
ed the critical area of the VT. A complete epicardial
apping procedure was not required in this patient. In 5 of
4 remaining patients with delayed enhancement, the scar
as predominantly intramural with minimal extension of
he scar toward either endocardium or epicardium. Map-
ing within the endocardium failed to identify suitable
arget sites or areas with isolated potentials in these patients.
cute response to catheter ablation. In 7 of 14 patients
ith delayed enhancement, in whom there was an endocar-
ial extension of the scar, at least 1 arrhythmia could be
blated from the endocardium (Tables 3 and 4). All ar-
hythmias (VTs in 2 patients and PVCs in 3 patients) could
e endocardially eliminated in 5 of 14 patients with delayed
nhancement. In the remaining 2 patients with endocardial
car extensions, 20 of 33 inducible VTs could be ablated
rom the endocardium. In 1 of these 2 patients, the scar was
redominantly intramural in location. In the other patient,
art of the scar was intramural and epicardial; a limited
picardial map failed to identify any critical epicardial target
ites. In this patient, VTs originated from the right and left
entricle and critical sites could be identified endocardially
n both ventricles.
In 2 of 14 patients with delayed enhancement, the scar
as predominantly located in the left ventricular epicar-
ium. An epicardial mapping procedure with transcuta-
eous epicardial access eliminated all 3 VTs in a patient
n whom a prior endocardial ablation procedure failed. A
imited epicardial ablation procedure was effective in
liminating the only VT in 1 of the patients when
adiofrequency energy was delivered within the greater
ardiac vein.
In the remaining 5 of 14 patients with delayed enhance-
ent, in whom the scar was predominantly located intra-
urally, radiofrequency ablation failed to eliminate the
argeted ventricular arrhythmias in all patients (VT in 2
atients and PVCs in 3 patients).
In the 15 patients without delayed enhancement, 9
atients had monomorphic PVCs, and 7 of 9 could be
ffectively ablated (4 in the right ventricle and 3 in the left
entricle). The remaining 6 patients had pleomorphic
VCs, and at least 1 morphology could be eliminated in all
ut 1 patient in whom no appropriate target sites could be
dentified by endocardial mapping. This resulted in a
ecrease of the PVC burden from 31  17% to 5.2  9%
p  0.005). VT was not inducible in any of these patients.
ollow-up. Total follow-up time was 19 11 months. All
ut 1 patient (n  8) with inducible VT received a
ardioverter defibrillator. One patient refused implantation
f a defibrillator. Six of the 14 patients (43%) with delayed
nhancement had recurrent arrhythmias (3 had VT, 3 had
VCs). Recurrences occurred only in patients in whom not
ll arrhythmias could be eliminated during the initial abla-
ion procedure. Four patients were on amiodarone before
he ablation procedure; this was discontinued 6 months after tblation in 1 patient (this was 24 months before his last
ollow-up); this patient had 1 episode of VT during the
ollow-up period. In the other patients, amiodarone was
ontinued.
The ejection fraction in patients without delayed en-
ancement increased from 0.37  0.09 to 0.51  0.17
ithin 6 months post-procedure (p  0.001). In patients
ith delayed enhancement, the ejection fraction did not
hange after ablation (0.36 0.09 vs. 0.44 0.12; p 0.2).
iscussion
ain findings. This study shows that scar tissue can be
dentified by DE-MRI in approximately 50% of patients
ith nonischemic cardiomyopathy and frequent PVCs or
onomorphic VT. The DE-MRI can be integrated into an
lectroanatomical map, and the location of the scar is a
eliable guide to catheter ablation. If the scar is endocardial,
ndocardial mapping and ablation will be necessary, and if
he scar is epicardial, this indicates that an epicardial
pproach is very likely to be needed for mapping and
blation. Of note, catheter ablation of frequent PVCs or VT
as unsuccessful in all patients who had a predominantly
ntramural scar. Therefore, an intramural scar on DE-MRI
dentifies patients in whom the critical arrhythmogenic
ubstrate might be difficult to reach with the catheter
echnology used in this study.
car and nonischemic cardiomyopathy. In this consecu-
ive series of patients with nonischemic cardiomyopathy
eferred for catheter ablation of frequent PVCs or VT, scar
as detected by DE-MRI in approximately 50% of patients.
hese results confirm that scar is present in a large propor-
ion of patients who have ventricular arrhythmias in the
bsence of coronary artery disease and prior myocardial
nfarction (1,2,9). However, this is the first study to show
hat the scar may be directly associated with a critical
omponent of the targeted PVCs or VT, and that the
ocation of the scar facilitates mapping and catheter
blation.
As in prior studies, the inducibility of monomorphic VT
orrelated with the scar burden (1). This suggests that there
ay be a threshold of scar volume above which re-entrant
T is likely to occur, as has been reported in patients with
schemic cardiomyopathy (10). Furthermore, none of the
atients without scar had inducible VT despite the presence
f a compromised ejection fraction. It must be kept in mind,
owever, that a reversible form of cardiomyopathy second-
ry to frequent PVCs might have accounted for a reduced
jection fraction in some of the patients without scar on
E-MRI (11).
mage registration. Pre-procedural scar registration al-
owed rapid integration of the potential arrhythmogenic
ubstrate into the electroanatomical map of the right or left
entricle. Our study further extends results from a prior
tudy that used positron emission tomography/computed
omography imaging to target ventricular arrhythmias by
l
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March 31, 2009:1138–45 DE-MRI and Arrhythmia in Cardiomyopathyocalizing scar tissue very precisely using DE-MRI (12).
he position of the scar in the wall of the ventricle proved
o be predictive of the location of the effective target sites.
hen the DE-MRI showed delayed enhancement pre-
ominantly in the epicardium or intramurally without
xtension to the endocardium, endocardial mapping and
blation was always unsuccessful. When an intramural scar
xtended to the epicardium, successful ablation was feasible
rom within the pericardial space. Therefore, scar location
n DE-MRI is a reliable indicator of whether an endocar-
ial or epicardial approach to mapping and ablation will be
eeded in the almost 50% of patients with nonischemic
ardiomyopathy and frequent PVCs or VT who have a
emonstrable scar.
atients without scar tissue. Scar can be identified in a
inority of patients with nonischemic cardiomyopathy (4).
n this study of patients with frequent PVCs and impaired
eft ventricular function in whom PVCs could be elimi-
ated, the left ventricular function either improved or
ormalized. A reversible form of PVC-induced cardiomy-
pathy has been described before (11) and might explain
mprovement of ejection fraction in these patients. The
rrhythmogenic substrate could not be identified by MRI in
his subset of patients.
tudy limitations. Not all forms of nonischemic cardio-
yopathy were included in this study, and it is possible that
he results do not apply to all types of nonischemic
ardiomyopathy.
Another limitation is that epicardial mapping from
ithin the pericardial space was not performed in all
atients with a failed endocardial ablation. Therefore, we
annot rule out that some of the ventricular arrhythmias
ssociated with intramural scar may have been successfully
blated using an epicardial approach. Larger studies includ-
ng especially patients with epicardial and intramural scar
re required to confirm our preliminary data. Furthermore,
car was defined by manual tracing and therefore might not
e as objective as a semiautomatic method that is frequently
sed to define scar in post-infarction patients (13).
linical implications. DE-MRI plays an important role in
atients with nonischemic cardiomyopathy who are candi-
ates for catheter ablation of frequent PVCs or VT. De-
ayed enhancement indicative of scar is present in approxi-
ately 50% of these patients, and if a scar is present, its
ocation can be used to plan the approach to catheter
blation. If the scar is epicardial and does not have an
ndocardial component, epicardial mapping and ablation
ay be necessary. On the other hand, if the scar isntramural and does not have an endocardial or epicardial
K
vxtension, catheter ablation is less likely to be successful, and
dditional attempts at pharmacologic therapy may be more
ppropriate than radiofrequency catheter ablation of the
requent PVCs or VT.
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